• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

series B

Fierce Fundraising Tracker image 2025
Biotech

Fierce Biotech Fundraising Tracker: Haya, NewLimit & more

Welcome to Fierce Biotech's Fundraising Tracker for 2025.
Gabrielle Masson , Darren Incorvaia May 8, 2025 8:50am
Pencil filling out Scantron test form

AIRNA preps for clinical test with $155M series B

Apr 1, 2025 7:00am
colorful brain art model

Newronika nets CE mark for adaptive DBS in Parkinson's disease

Mar 26, 2025 10:36am
feather arrows

Atalanta loads crossbow with $97M, 2 Big Pharmas in tow

Jan 28, 2025 7:00am
A double helix of DNA made up of musical notes The notes are in black against a grey-white background

Tune Tx's $175M series B to fund epigenetic HBV therapy's trials

Jan 13, 2025 8:23am
DNA genome CRISPR gene editing

Pleno raises $25M for commercial launch, plucks new CEO

Dec 12, 2024 7:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings